Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Shadduck, RK' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 63 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Zeigler, ZR; Shadduck, RK; Gryn, JF; Rintels, PB; George, JN; Besa, EC; Bodensteiner, D; Silver, B; Kramer, RE
      Cryoprecipitate poor plasma does not improve early response in primary adult thrombotic thrombocytopenic purpura (TTP)

      JOURNAL OF CLINICAL APHERESIS
    2. Shadduck, RK; Gilmore, GL; Lister, J
      Role of serum-free medium in the ex vivo expansion of human cord blood hematopoietic stem cells

      STEM CELLS
    3. Gilmore, GL; DePasquale, DK; Lister, J; Shadduck, RK
      Ex vivo expansion of human umbilical cord blood and peripheral blood CD34(+) hematopoietic stem cells

      EXPERIMENTAL HEMATOLOGY
    4. Gilmore, GL; DePasquale, DK; Shadduck, RK
      Protective effects of BB-10010 treatment on chemotherapy-induced neutropenia in mice

      EXPERIMENTAL HEMATOLOGY
    5. Zeigler, ZR; Kelton, JG; Moore, JC; Shadduck, RK; Andrews, DF; Nath, R; Agha, M
      Calpain activity in bone marrow transplant-associated thrombotic thrombocytopenic purpura

      BONE MARROW TRANSPLANTATION
    6. Chockalingam, A; Jalil, A; Shadduck, RK; Lister, J
      Allogeneic peripheral blood stem cell transplantation for hypereosinophilic syndrome with severe cardiac dysfunction

      BONE MARROW TRANSPLANTATION
    7. Scheller, M; Foerster, J; Heyworth, CM; Waring, JF; Lohler, J; Gilmore, GL; Shadduck, RK; Dexter, TM; Horak, I
      Altered development and cytokine responses of myeloid progenitors in the absence of transcription factor, interferon consensus sequence binding protein

      BLOOD
    8. ANTHONY MT; ZEIGLER ZR; LISTER J; RAYMOND JM; SHADDUCK RK; KRAMER RE; GRYN JF; RINTELS PB; BESA EC; GEORGE JN; SILVER B; JOYCE R; BODENSTEINER D
      PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1) ANTIGEN LEVELS IN PRIMARY TTPAND SECONDARY TTP POST-BONE MARROW TRANSPLANTATION

      American journal of hematology
    9. GILMORE GL; LISTER J; SHADDUCK RK
      EX-VIVO EXPANSION OF HUMAN CD34(-BLOOD AND PERIPHERAL-BLOOD WITH FLT-3 LIGAND [FL] AND THROMBOPOIETIN [TPO]() CELLS FROM CORD)

      Experimental hematology
    10. BRUMMER E; GILMORE GL; SHADDUCK RK; STEVENS DA
      DEVELOPMENT OF MACROPHAGE ANTICRYPTOCOCCAL ACTIVITY IN-VITRO IS DEPENDENT ON ENDOGENOUS M-CSF

      Cellular immunology (Print)
    11. ROSENFELD CS; ZEIGLER ZR; SHADDUCK RK; NILSSON B
      PHASE-II STUDY OF ROQUINIMEX IN MYELODYSPLASTIC SYNDROME

      American journal of clinical oncology
    12. ILDSTAD ST; KAUFMAN CL; SHADDUCK RK; WHELTON PM; DEMUTH B; MCGUIRE LM; SCHEA H; CRILLEY PA
      RELATIVE DISTRIBUTION OF FACILITATING CELLS (FC) VS. HEMATOPOIETIC STEM-CELLS (HSC) IN G-CSF MOBILIZED PERIPHERAL-BLOOD

      Blood
    13. ILDSTAD ST; CRILLEY PA; SHADDUCK RK; KAUFMAN CL; MIRRO J; BRODSKY I; BRUGGER W; GAJEWSKI JL; PRZEPIORKA D; STYLER MJ; LISTER J; TOPOLSKY DL; MANZ M; KANZ L; CHAMPLIN RL
      GRAFT ENGINEERING - THE FACILITATING CELL (FC) PROTOCOL IN HLA MISMATCHED BMT FOR HEMATOLOGIC MALIGNANCY

      Blood
    14. BRUMMER E; GILMORE GL; SHADDUCK RK; STEVENS DA
      ANTIBODY TO MCSF RECEPTOR BLOCKS DEVELOPMENT OF MACROPHAGE ANTI-CRYPTOCOCCAL ACTIVITY IN-VITRO, INDICATING DEVELOPMENT IS DEPENDENT ON ENDOGENOUS MCSF

      Clinical infectious diseases
    15. DUA A; ZEIGLER ZR; SHADDUCK RK; NATH R; ANDREWS DF; AGHA M
      APHERESIS IN GRADE-4 BONE-MARROW TRANSPLANT ASSOCIATED THROMBOTIC MICROANGIOPATHY - A CASE SERIES

      Journal of clinical apheresis
    16. ZEIGLER ZR; ROSENFELD CS; ANDREWS DF; NEMUNAITIS J; RAYMOND JM; SHADDUCK RK; KRAMER RE; GRYN JF; RINTELS PB; BESA EC; GEORGE JN
      PLASMA VON-WILLEBRAND-FACTOR ANTIGEN (VWF-AG) AND THROMBOMODULIN (TM)LEVELS IN ADULT THROMBOTIC THROMBOCYTOPENIC PURPURA HEMOLYTIC-UREMIC SYNDROMES (TTP HUS) AND BONE-MARROW TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY (BMT-TM)/

      American journal of hematology
    17. SHADDUCK RK; FISCHER BC; DEPASQUALE DK; GILMORE GL
      PARADOXICAL STIMULATION OF NORMAL AND LEUKEMIC RAT HEMATOPOIESIS BY MONOCLONAL-ANTIBODY TO CSF-1 RECEPTOR

      Experimental hematology
    18. LOGAN TF; GOODING W; KIRKWOOD JM; SHADDUCK RK
      TUMOR-NECROSIS-FACTOR ADMINISTRATION IS ASSOCIATED WITH INCREASED ENDOGENOUS PRODUCTION OF M-CSF AND G-CSF HUT NOT GM-CSF IN HUMAN CANCER-PATIENTS

      Experimental hematology
    19. ZEIGLER ZR; SHADDUCK RK; NATH R; ANDREWS DF
      PILOT-STUDY OF COMBINED CRYOSUPERNATANT AND PROTEIN-A IMMUNOADSORPTION EXCHANGE IN THE TREATMENT OF GRADE 3-4 BONE-MARROW TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY

      Bone marrow transplantation
    20. SCHUHMACHERS G; ARIIZUMI K; KITAJIMA T; EDELBAUM D; XU S; SHADDUCK RK; GILMORE GL; TAYLOR RS; BERGSTRESSER PR; TAKASHIMA A
      UVB RADIATION INTERRUPTS CYTOKINE-MEDIATED SUPPORT OF AN EPIDERMAL-DERIVED DENDRITIC CELL-LINE (XS52) BY A DUAL MECHANISM

      Journal of investigative dermatology
    21. GILMORE GL; DEPASQUALE DK; SHADDUCK RK
      BB10010, A SYNTHETIC VARIANT OF MIP-1-ALPHA REDUCES NEUTROPENIC INTERVAL IN CYCLOPHOSPHAMIDE-TREATED MICE

      Blood
    22. ZEIGLER ZR; SHADDUCK RK; ANDREWS DF; NATH R; AGHA ME
      PLASMINOGEN-ACTIVATOR INHIBITOR LEVELS POST BONE-MARROW TRANSPLANTATION CORRELATE WITH VENOOCCLUSIVE DISEASE

      Blood
    23. ZEIGLER ZR; SHADDUCK RK; ANDREWS DF; NATH R; AGHA ME
      THROMBOMODULIN LEVELS POST-BONE MARROW TRANSPLANTATION CORRELATE WITHVENOOCCLUSIVE DISEASE

      Blood
    24. SHADDUCK RK; FISCHER BC; GILMORE GL
      PARADOXICAL STIMULATION OF RAT M-CSF RESPONSIVE CELLS BY ANTIRECEPTORANTIBODY

      Experimental hematology
    25. ROSENFELD CS; RYBKA WB; WEINBAUM D; CARRIGAN DR; KNOX KK; ANDREWS DF; SHADDUCK RK
      LATE GRAFT FAILURE DUE TO DUAL BONE-MARROW INFECTION WITH VARIANT-A AND VARIANT-B OF HUMAN HERPESVIRUS-6

      Experimental hematology
    26. GILMORE GL; DEPASQUALE DK; FISCHER BC; SHADDUCK RK
      ENHANCEMENT OF MONOCYTOPOIESIS BY GRANULOCYTE-COLONY-STIMULATING FACTOR - EVIDENCE FOR SECONDARY CYTOKINE EFFECTS IN-VIVO

      Experimental hematology
    27. SCHWINGHAMMER TL; BLOOM EJ; ROSENFELD CS; WILSON JW; PRZEPIORKA D; SHADDUCK RK
      HIGH-DOSE CYCLOSPORINE AND CORTICOSTEROIDS FOR PROPHYLAXIS OF ACUTE AND CHRONIC GRAFT-VERSUS-HOST DISEASE

      Bone marrow transplantation
    28. NEMUNAITIS J; ROSENFELD CS; ASH R; FREEDMAN MH; DEEG HJ; APPELBAUM F; SINGER JW; FLOMENBERG N; DALTON W; ELFENBEIN GJ; RIFKIN R; RUBIN A; AGOSTI J; HAYES FA; HOLCENBERG J; SHADDUCK RK
      PHASE-III RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF RHGM-CSF FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Bone marrow transplantation
    29. ROSENFELD CS; SHADDUCK RK; ZEIGLER ZR; ANDREWS F; NEMUNAITIS J
      CYCLOPHOSPHAMIDE-MOBILIZED PERIPHERAL-BLOOD STEM-CELLS IN PATIENTS WITH LYMPHOID MALIGNANCIES

      Bone marrow transplantation
    30. ZEIGLER ZR; SHADDUCK RK; NEMUNAITIS J; ANDREWS DF; ROSENFELD CS
      BONE-MARROW TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY - A CASESERIES

      Bone marrow transplantation
    31. ROSENFELD CS; THIELE DL; SHADDUCK RK; ZEIGLER ZR; SCHINDLER J
      EX-VIVO PURGING OF ALLOGENEIC MARROW WITH L-LEUCYL-L-LEUCINE METHYL-ESTER - A PHASE-I STUDY

      Transplantation
    32. TAKASHIMA A; EDELBAUM D; KITAJIMA T; SHADDUCK RK; GILMORE GL; XU S; TAYLOR RS; BERGSTRESSER PR; ARIIZUMI K
      COLONY-STIMULATING FACTOR-I SECRETED BY FIBROBLASTS PROMOTES THE GROWTH OF DENDRITIC CELL-LINES (XS SERIES) DERIVED FROM MURINE EPIDERMIS

      The Journal of immunology
    33. DERYUGINA EI; RATNIKOV BI; BOURDON MA; GILMORE GL; SHADDUCK RK; MULLERSIEBURG CE
      IDENTIFICATION OF A GROWTH-FACTOR FOR PRIMARY MURINE STROMA AS MACROPHAGE-COLONY-STIMULATING FACTOR

      Blood
    34. DUA A; ZEIGLER ZR; SHADDUCK RK; ANDREWS DF; NATH R; AGHA ME
      A PROSPECTIVE-STUDY OF BONE-MARROW TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY (BMT-TM) IN ALLOGENEIC (ALLO) BMT AND CLINICAL CORRELATES

      Blood
    35. BUTT AA; ZEIGLER ZR; KELTON JG; MOORE JC; SHADDUCK RK; ANDREWS DF; NATH R; AGHA ME
      CALPAIN ACTIVITY IN BONE-MARROW TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY (BMT-TM)

      Blood
    36. GILMORE GL; DEPASQUALE DK; FISCHER BC; SHADDUCK RK
      IN-VIVO EFFECTS OF MONOCLONAL-ANTIBODY TO THE MURINE CSF-1 RECEPTOR ON MICE RECOVERING FROM CYCLOPHOSPHAMIDE

      Blood
    37. ROSENFELD CS; ZEIGLER ZR; SHADDUCK RK; NILSSON BI
      ROQUINIMEX (LINOMIDE)(R) IN MYELODYSPLASTIC SYNDROME - A PHASE-II STUDY

      Blood
    38. ANDREWS DF; ZEIGLER Z; NATH R; AGHA M; SHADDUCK RK; GEYER S; MCLEAN G
      TRANSJUGULAR LIVER-BIOPSY (TLB) MARROW TRANSPLANT RECIPIENTS - RESULTS FROM A NEW TECHNIQUE

      Blood
    39. VALILLS PN; ZEIGLER ZR; SHADDUCK RK; ANDREWS DF; NATH R; AGHA ME
      A PROSPECTIVE-STUDY OF BONE-MARROW TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY (BMT-TM) IN AUTOLOGOUS (AUTO) AND ALLOGENEIC (ALLO) BMT

      Blood
    40. FABER E; ANDREWS DF; SHADDUCK RK; GEYER S; AGHA ME
      IMPROVED EFFICIENCY OF GROWTH-INHIBITION OF BCR-ABL POSITIVE CELLS BYANTISENSE OLIGODEOXYNUCLEOTIDES-CHOLESTEROL

      Blood
    41. GILMORE GI; SHADDUCK RK
      INHIBITION OF DAY-12 SPLEEN COLONY-FORMING-UNITS BY A MONOCLONAL-ANTIBODY TO THE MURINE MACROPHAGE MONOCYTE COLONY-STIMULATING FACTOR-RECEPTOR/

      Blood
    42. GILMORE GL; SHADDUCK RK
      INHIBITION OF DAY 12 CFU-S COLONIES BY A MONOCLONAL-ANTIBODY TO THE MURINE M-CSF RECEPTOR

      The FASEB journal
    43. ROSENFELD C; SHADDUCK RK; ZEIGLER ZR; ANDREWS F; SCHAEFER P; NEMUNAITIS J
      CYCLOPHOSPHAMIDE MOBILIZED PERIPHERAL-BLOOD STEM-CELLS IN PATIENTS WITH LYMPHOID MALIGNANCIES - EFFECT OF ADDED COLONY-STIMULATING FACTORS

      Experimental hematology
    44. ROSENFELD CS; GREMBA C; SHADDUCK RK; ZEIGLER ZR; NEMUNAITIS J
      ENGRAFTMENT WITH PERIPHERAL-BLOOD STEM-CELLS USING NONCONTROLLED-RATECRYOPRESERVATION - COMPARISON WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION

      Experimental hematology
    45. JONES CM; PODDAR S; GOLDSTEIN R; KRUPEN KI; KERMAN RH; PRINCE C; SHADDUCK RK
      HUMAN MCF ACTIVATES MONOCYTES TO PRODUCE IL-1 BUT NOT TNF OR CSF-1

      Immunobiology
    46. DALLA KP; ZEIGLER ZR; SHADDUCK RK
      ALPHA-INTERFERON IN MYELOFIBROSIS - A CASE-REPORT

      British Journal of Haematology
    47. ANDREWS DF; SHADDUCK RK; ZEIGLER ZR; GEYER S; GEORGE M; ROSENFELD CS; NEMUNAITIS JJ
      C-KIT-BLOOD STEM-CELL (PBSC) MOBILIZATION - HIGH-DOSE CYCLOPHOSPHAMIDE (HDC) PLUS G-CSF COMPARED TO GROWTH-FACTOR (CSFS) ALONE( AND CD34+ PERIPHERAL)

      Blood
    48. ZEIGLER ZR; SHADDUCK RK; ANDREWS DF; ROSENFELD CS
      SUCCESSFUL TREATMENT OF GRADE 3-4 BONE-MARROW TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY (BMT-TM) WITH COMBINED CRYOSUPERNATANT (CRYO) AND PROTEIN-A IMMUNOADSORPTION (PAI) EXCHANGES

      Blood
    49. NEMUNAITIS J; APPELBAUM FR; LILLEBY K; BUHLES WC; ROSENFELD C; ZEIGLER ZR; SHADDUCK RK; SINGER JW; MEYER W; BUCKNER CD
      PHASE-I STUDY OF RECOMBINANT INTERLEUKIN-1-BETA IN PATIENTS UNDERGOING AUTOLOGOUS BONE-MARROW TRANSPLANT FOR ACUTE MYELOGENOUS LEUKEMIA

      Blood
    50. ROSENFELD CS; NEMUNAITIS J; SHERER CR; ZEIGLER ZR; SHADDUCK RK
      C-KIT LIGAND AUGMENTS GRANULOCYTE-MACROPHAGE COLONY GROWTH FROM PATIENTS WITH 5Q-SYNDROME

      Stem cells
    51. NEMUNAITIS J; ALBO V; ZEIGLER ZR; SHADDUCK RK; ROSENFELD CS
      REDUCTION OF ALLOGENEIC TRANSPLANT MORBIDITY BY COMBINING PERIPHERAL-BLOOD AND BONE-MARROW PROGENITOR CELLS

      Leukemia & lymphoma
    52. MATULONIS U; ROSENFELD CS; SHADDUCK RK
      PREVENTION OF LEGIONELLA INFECTIONS IN A BONE-MARROW TRANSPLANT UNIT - MULTIFACETED APPROACH TO DECONTAMINATION OF A WATER-SYSTEM

      Infection control and hospital epidemiology
    53. SCHWINGHAMMER TL; FLEMING RA; ROSENFELD CS; PRZEPIORKA D; SHADDUCK RK; BLOOM EJ; STEWART CF
      DISPOSITION OF TOTAL AND UNBOUND ETOPOSIDE FOLLOWING HIGH-DOSE THERAPY

      Cancer chemotherapy and pharmacology
    54. SHADDUCK RK; ZEIGLER ZR; ROSENFELD CS; NEMUNAITIS J; ANDREWS DF
      BONE-MARROW TRANSPLANT ASSOCIATED THROMBOTIC MICROANGIOPATHY - A CASESERIES

      Experimental hematology
    55. SHADDUCK RK; GILMORE G; FISCHER B; DEPASQUALE D
      INHIBITION OF G-CSF ENHANCED RECOVERY AFTER CYTOTOXIC THERAPY BY ANTISERUM TO M-CSF - SECONDARY CYTOKINE INTERACTIONS IN GROWTH FACTOR-STIMULATED RECOVERY

      Experimental hematology
    56. ROSENFELD CS; NEMUNAITIS J; SHERER CR; ZEIGLER ZR; SHADDUCK RK
      C-KIT LIGAND AUGMENTS GRANULOCYTE-MACROPHAGE COLONY GROWTH FROM PATIENTS WITH 5Q-SYNDROME

      Experimental hematology
    57. SHADDUCK RK; WAHEED A; MANGAN KF; ROSENFELD CS
      PREPARATION OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE RECEPTOR FOR MURINE COLONY-STIMULATING FACTOR-I

      Experimental hematology
    58. TEMELES DS; MCGRATH HE; KITTLER ELW; SHADDUCK RK; KISTER VK; CRITTENDEN RB; TURNER BL; QUESENBERRY PJ
      CYTOKINE EXPRESSION FROM BONE-MARROW-DERIVED MACROPHAGES

      Experimental hematology
    59. NEMUNAITIS J; APPELBAUM FR; SINGER JW; LILLEBY K; WOLFF S; GREER JP; BIERMAN P; RESTA D; CAMPION M; LEVITT D; ZEIGLER Z; ROSENFELD C; SHADDUCK RK; BUCKNER CD
      PHASE-I TRIAL WITH RECOMBINANT HUMAN INTERLEUKIN-3 IN PATIENTS WITH LYMPHOMA UNDERGOING AUTOLOGOUS BONE-MARROW TRANSPLANTATION

      Blood
    60. ROSENFELD CS; SHADDUCK RK; NEMUNAITIS I; ZEIGLER ZR
      EX-VIVO PURGING OF ALLOGENEIC MARROW WITH L-LEUCYL-L-LEUCINE METHYLESTER - PRELIMINARY-RESULTS OF THE PHASE-I STUDY

      Blood
    61. ZEIGLER ZR; ROSENFELD CS; ANDREWS F; NEMUNAITIS J; SHADDUCK RK
      THROMBOMODULIN (TM) AND VON-WILLEBRAND ANTIGEN (VWF, AG) IN THROMBOTIC THROMBOCYTOPENIA PURPURA (TTP), TTP HEMOLYTIC UREMIC SYNDROME (HUS),AND BONE-MARROW TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY (BMT-TM)/

      Blood
    62. NEMUNAITIS J; ROSENFELD C; ASH R; FLOMENBERG N; FRIEDMAN M; DEEG J; APPELBAUM F; SINGER JW; DALTON W; ELFENBEIN G; RIFKIN R; RUBIN A; AGOSTI J; HAYES FA; SHADDUCK RK
      PHASE-III DOUBLE-BLIND TRIAL OF RHGM-CSF (SARGRAMOSTIN) FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANT (BMT)

      Blood
    63. ZEIGLER ZR; SHADDUCK RK; ANDREWS F; NEMUNAITIS J; ROSENFELD CS
      THROMBOMODULIN (TM) AND VON-WILLEBRAND ANTIGEN (VWF, AG) LEVELS IN BONE-MARROW TRANSPLANT ASSOCIATED THROMBOTIC MICROANGIOPATHY (BMT-TM)

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 16/01/21 alle ore 16:11:36